Register for the 7th RNAi-Based Therapeutics Summit
Please select the appropriate price when booking. Bookings are subject to approval.
All prices are shown in USD.
Recently RSVP'ed!
Register by Friday, January 27 & Save up to $100
Drug Developer Pricing*
Conference + Workshop Day
(Save $100)
$4,097
On the Door: $4,197
Conference Only
(Save $100)
$2,899
On the Door: $2,999
Academic & Discounted Pricing**
Conference + Workshop Day
(Save $100)
$3,497
On the Door: $3,597
Conference Only
(Save $100)
$2,499
On the Door: $2,599
Service Provider Pricing***
Conference + Workshop Day
(save $100)
$4,997
On the Door: $5,097
Conference Only
(save $100)
$3,599
On the Door: $3,699
* To be eligible for this price, the group or individuals must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services.
** To be eligible for this price, the group or individual must be full-time academic(s).
*** If you are a solution or service provider, have you considered sponsoring this event? Sponsorship includes multiple passes at a discounted rate. Inquire to learn more.
Unlock Group Discounts
Maximize value for money using special team discounts: Please note that discounts are only valid when two or more delegates from one company book and pay at the same time.
10% Off
When registering 2 attendees from one company
15% Off
When registering 3 attendees from one company
20% Off
When registering 4+ attendees from one company
Need Assistance?
If you have any questions about registration pricing, discounts or would like help with the booking process, contact us and one of the team will get back to you.
Explore the Full Event Guide
- 25+ expert speakers from pioneering biotechs and large pharma, including Sanegene Bio, AbbVie, Judo Bio, and more, sharing exclusive data and case studies.
- Actionable insights to conquer extrahepatic delivery for CNS, muscle, and cardiac tissues with novel strategies like aptamers, bispecifics, and exosomes.
- Dedicated deep-dives on the hottest applications: from obesity and metabolic disease to neurology, oncology, and more.
- Critical regulatory and CMC strategies to overcome complex synthesis, scale-up, and IND-enabling hurdles for late-stage clinical success.
